Quick Takeaways
- This page summarizes Devdatt Kurdikar's Form 4 filing for ZIMMER BIOMET HOLDINGS, INC. (ZBH).
- 1 reported transaction and 1 derivative row are listed below.
- Filing timestamp: 05 Jan 2026, 16:06.
Devdatt Kurdikar - 31 Dec 2025 Form 4 Insider Report for ZIMMER BIOMET HOLDINGS, INC. (ZBH)
- Role
- Director
- Signature
- /s/ Matthew R. St. Louis, Attorney-in-Fact for Devdatt Kurdikar (power of attorney previously filed)
- Issuer symbol
- ZBH
- Transactions as of
- 31 Dec 2025
- Net transactions value
- $0
- Form type
- 4
- Filing time
- 05 Jan 2026, 16:06:20 UTC
- Previous filing
- 01 Dec 2025
- Next filing
- 02 Apr 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"Devdatt Kurdikar filed Form 4 for ZIMMER BIOMET HOLDINGS, INC. (ZBH) on 05 Jan 2026."
What Changed
- Previous filing in this sequence was filed on 01 Dec 2025.
- Current net transaction value: $0.
Why This Matters
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Source Evidence
Filed on Form 4
See Original Filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Kurdikar Devdatt | Director | 345 E. MAIN STREET, WARSAW | /s/ Matthew R. St. Louis, Attorney-in-Fact for Devdatt Kurdikar (power of attorney previously filed) | 05 Jan 2026 | 0001910621 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ZBH | Phantom Stock Units | Award | $0 | +152 | +9.4% | $0.000000 | 1,770 | 31 Dec 2025 | Common Stock | 152 | $90.33 | Direct | F1, F2, F3, F4 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
| Id | Content |
|---|---|
| F1 | The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. |
| F2 | The Conversion or Exercise Price of Derivative Security is 1-for-1. |
| F3 | Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. |
| F4 | Includes 3.876 phantom stock units accrued on October 31, 2025 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. |